Absorbable bone-wax substitutes: materials, biological response, and clinical evidence
Frontiers in Bioengineering and Biotechnology · 16.11.2026 · 14
DOI: 10.3389/fbioe.2026.1969375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 16.11.2026. Verfasst von Fulong Zhong und 6 weiteren Autor:innen. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Provincial Science and Technology Support Program.
Abstract (Originalsprache)
Background
Absorbable bone-wax substitutes are designed to stop bone bleeding without leaving a permanent barrier to repair. They need to remain in place until bleeding is controlled and then clear without harmful tissue reactions.
Objective
To examine how composition and clearance affect hemostasis, bone repair, and clinical outcomes.
Methods
We documented a focused narrative search through 23 October 2026. Sources included Europe PMC, cited references, publisher records, and official device documents. The core set contained 37 primary reports. We assessed the methods and limitations of clinical and selected animal reports. We did not perform a meta-analysis.
Results
The core set included four bench-only reports, 29 animal reports, three randomized clinical reports, and one single-arm clinical report. Soluble polymers, polymer–polysaccharide blends, degradable polymers, and self-setting putties differ in how long they remain at the site and how they clear. Several animal studies found less interference with healing than with conventional wax. This does not necessarily mean that the substitute stimulates bone formation. Clinical findings varied by product and procedure. Historical clinical series and separate safety reports provided context but were not counted as contemporary comparative trials.
Conclusion
Absorbability may reduce the problems caused by retained material, but it does not alone establish better clinical outcomes. Studies should distinguish initial bleeding control from sustained control, dissolution from clearance, and less inhibition of healing from increased bone formation. Comparative trials need clear dosing, reapplication and rescue criteria, suitable controls, and follow-up for infection and union.
Förderung
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Zhong, F., Yang, L., Zhou, Q., Ren, J., Liu, T., Cai, B., & Li, H. (2026). Absorbable bone-wax substitutes: materials, biological response, and clinical evidence. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1969375
Vancouver
Zhong F, Yang L, Zhou Q, Ren J, Liu T, Cai B, et al. Absorbable bone-wax substitutes: materials, biological response, and clinical evidence. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1969375
BibTeX
@article{Zhong2026,
author = {Zhong, Fulong and Yang, Long and Zhou, Qing and Ren, Jiaji and Liu, Tielong and Cai, Bin and Li, Hong},
title = {Absorbable bone-wax substitutes: materials, biological response, and clinical evidence},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2026},
volume = {14},
doi = {10.3389/fbioe.2026.1969375}
}
EUVIMED